News
3 Poster presentations by Ella Widigson and collaborators
at the 21st Congress of European Crohn’s and Colitis Organisation (ECCO) - Inflammatory Bowel Diseases.
We congratulate Ella Widigson and collaborators in Odense/Denmark on their poster presentation at ECCO 2026 from 18 to 21 February in Stockholm/Sweden! The abstracts are entitled as follows: 1) Therapeutic Drug Monitoring of ustekinumab and vedolizumab in Inflammatory Bowel Disease: Expanding Flexibility Through PK-PD Time-Based Thresholds, 2) Therapeutic Drug Monitoring of ustekinumab and vedolizumab in Inflammatory Bowel Disease: A systematic review to define exposure thresholds for endoscopic remission and 3) The protocol of an independent, randomized, controlled, Danish, multicenter trial of Model-Informed Precision Dosing of ustekinumab and vedolizumab in Inflammatory Bowel Disease.